Research Paper Volume 12, Issue 14 pp 14718—14735

Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling

Figure 3. DMC-BH induces cell cycle arrest in GSCs. (A) PI flow cytometry analysis of DMC-BH-treated GSCs. (B) Western analysis of Cdc2 and cyclin B1 in DMC-BH-treated GSCs; n =3.